Request for Covid-19 Impact Assessment of this Report
Geographically, the global Active Pharmaceutical Ingredient market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.
North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Active Pharmaceutical Ingredient market in North America.
Significant participants active in the global Active Pharmaceutical Ingredient market include: Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Novartis AG, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Bayer AG, F. Hoffmann-La Roche Ltd., Pfizer Inc....
Global Active Pharmaceutical Ingredient Market Segmentation:
Active Pharmaceutical Ingredient market, by Active Pharmaceutical Ingredient type:
Synthetic chemical API
Branded/ Innovative
Generic/Non- Branded
Biological API
Biotech
Biosimilar
High potency active pharmaceutical ingredients(HPAPI)
…
Active Pharmaceutical Ingredient market, by Application:
Captive (or in-house) Manufacturing
Contract Manufacturing
…
Active Pharmaceutical Ingredient Market Research Report 2014-2026, by region:
North America
The U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Pan Asia Pacific
China
Japan
South Korea
South East Asia Region
India
Australia
Middle East and Africa
Saudi Arabia
UAE
Qatar
Egypt
Nigeria
South Africa
Rest of MEA
The database is running updated by a group of research experts to always reflect the latest trends and information.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Active Pharmaceutical Ingredient by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Active Pharmaceutical Ingredient Market-Segmentation
4.1 By Type
4.1.1 Synthetic chemical API
4.1.2 Branded/ Innovative
4.1.3 Generic/Non- Branded
4.1.4 Biological API
4.1.5 Biotech
4.1.6 Biosimilar
4.1.7 High potency active pharmaceutical ingredients(HPAPI)
4.2 By End-User/Application Industry
4.2.1 Captive (or in-house) Manufacturing
4.2.2 Contract Manufacturing
4.3 By Geography
4.3.1 North America Active Pharmaceutical Ingredient Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Active Pharmaceutical Ingredient Production from 2014-2020
4.3.1.2 North America Active Pharmaceutical Ingredient Consumption from 2014-2020
4.3.1.3 North America Active Pharmaceutical Ingredient Import and Export from 2014-2020
4.3.1.4 North America Active Pharmaceutical Ingredient Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Active Pharmaceutical Ingredient Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Active Pharmaceutical Ingredient Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Active Pharmaceutical Ingredient Participants Value ($) and Market Share (%) in 2019
4.3.2 Europe Active Pharmaceutical Ingredient Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Active Pharmaceutical Ingredient Production from 2014-2020
4.3.2.2 Europe Active Pharmaceutical Ingredient Consumption from 2014-2020
4.3.2.3 Europe Active Pharmaceutical Ingredient Import and Export from 2014-2020
4.3.2.4 Europe Active Pharmaceutical Ingredient Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Active Pharmaceutical Ingredient Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Active Pharmaceutical Ingredient Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Active Pharmaceutical Ingredient Participants Value ($) and Market Share (%) in 2019
4.3.3 Asia-Pacific Active Pharmaceutical Ingredient Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Active Pharmaceutical Ingredient Production from 2014-2020
4.3.3.2 Asia-Pacific Active Pharmaceutical Ingredient Consumption from 2014-2020
4.3.3.3 Asia-Pacific Active Pharmaceutical Ingredient Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Active Pharmaceutical Ingredient Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Active Pharmaceutical Ingredient Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Active Pharmaceutical Ingredient Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Active Pharmaceutical Ingredient Participants Value ($) and Market Share (%) in 2019
4.3.4 Latin America Active Pharmaceutical Ingredient Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Active Pharmaceutical Ingredient Production from 2014-2020
4.3.4.2 Latin America Active Pharmaceutical Ingredient Consumption from 2014-2020
4.3.4.3 Latin America Active Pharmaceutical Ingredient Import and Export from 2014-2020
4.3.4.4 Latin America Active Pharmaceutical Ingredient Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Active Pharmaceutical Ingredient Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Active Pharmaceutical Ingredient Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Active Pharmaceutical Ingredient Participants Value ($) and Market Share (%) in 2019
4.3.5 Middle East & Africa Active Pharmaceutical Ingredient Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Active Pharmaceutical Ingredient Production from 2014-2020
4.3.5.2 Middle East & Africa Active Pharmaceutical Ingredient Consumption from 2014-2020
4.3.5.3 Middle East & Africa Active Pharmaceutical Ingredient Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Active Pharmaceutical Ingredient Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Active Pharmaceutical Ingredient Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Active Pharmaceutical Ingredient Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Active Pharmaceutical Ingredient Participants Value ($) and Market Share (%) in 2019
5. Competitive Intelligence – Company Profiles
5.1 Sun Pharmaceutical Industries Ltd.
5.1.1 Sun Pharmaceutical Industries Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Sun Pharmaceutical Industries Ltd. Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Merck & Co., Inc.
5.2.1 Merck & Co., Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Merck & Co., Inc. Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Novartis AG
5.3.1 Novartis AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Novartis AG Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Boehringer Ingelheim International GmbH
5.4.1 Boehringer Ingelheim International GmbH Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Boehringer Ingelheim International GmbH Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Teva Pharmaceutical Industries Ltd.
5.5.1 Teva Pharmaceutical Industries Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Teva Pharmaceutical Industries Ltd. Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Bayer AG
5.6.1 Bayer AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Bayer AG Sales, Growth Rate and Global Market Share from 2014-2020
5.7 F. Hoffmann-La Roche Ltd.
5.7.1 F. Hoffmann-La Roche Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 F. Hoffmann-La Roche Ltd. Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Pfizer Inc.
5.8.1 Pfizer Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Pfizer Inc. Sales, Growth Rate and Global Market Share from 2014-2020
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of the Global Active Pharmaceutical Ingredient Market from 2021-2026
7.1 Future Forecast of Global Active Pharmaceutical Ingredient Market from 2021-2026 Segment by Region
7.2 Future Forecast of the Global Active Pharmaceutical Ingredient Market from 2021-2026 Segment by Types
7.3 Future Forecast of the Global Active Pharmaceutical Ingredient Market from 2021-2026 Segment by End-User/Applications
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
9 Disclaimer
Global Active Pharmaceutical Ingredient Market Value ($) and Growth Rate of Active Pharmaceutical Ingredient from 2014-2026
Global Active Pharmaceutical Ingredient Production and Growth Rate Segment by Product Types from 2014-2026F
Global Active Pharmaceutical Ingredient Consumption and Growth Rate Segment by End-User/Application from 2014-2026E
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Active Pharmaceutical Ingredient Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Active Pharmaceutical Ingredient Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Synthetic chemical API of Active Pharmaceutical Ingredient
Figure Branded/ Innovative of Active Pharmaceutical Ingredient
Figure Generic/Non- Branded of Active Pharmaceutical Ingredient
Figure Biological API of Active Pharmaceutical Ingredient
Figure Biotech of Active Pharmaceutical Ingredient
Figure Biosimilar of Active Pharmaceutical Ingredient
Figure High potency active pharmaceutical ingredients(HPAPI) of Active Pharmaceutical Ingredient
Table Global Active Pharmaceutical Ingredient Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Active Pharmaceutical Ingredient Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Captive (or in-house) Manufacturing of Active Pharmaceutical Ingredient
Figure Contract Manufacturing of Active Pharmaceutical Ingredient
Table Global Active Pharmaceutical Ingredient Production Value ($) by Regions
Table Global Active Pharmaceutical Ingredient Production Value Share by Regions
Table Global Active Pharmaceutical Ingredient Production by Regions
Table Global Active Pharmaceutical Ingredient Production Share by Regions
Table Global Active Pharmaceutical Ingredient Consumption by Regions
Table Global Active Pharmaceutical Ingredient Consumption Share by Regions
Figure North America Active Pharmaceutical Ingredient Production and Growth Rate from 2014-2020
Figure North America Active Pharmaceutical Ingredient Consumption and Growth Rate from 2014-2020
Table North America Active Pharmaceutical Ingredient Import and Export from 2014-2020
Table North America Active Pharmaceutical Ingredient Value ($) and Growth (%) by Type from 2019-2020
Table North America Active Pharmaceutical Ingredient Value ($) and Growth (%) by Application from 2019-2020
Table North America Active Pharmaceutical Ingredient Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Active Pharmaceutical Ingredient Participants Value ($) and Market Share (%) in 2019
Figure Europe Active Pharmaceutical Ingredient Production and Growth Rate from 2014-2020
Figure Europe Active Pharmaceutical Ingredient Consumption and Growth Rate from 2014-2020
Table Europe Active Pharmaceutical Ingredient Import and Export from 2014-2020
Table Europe Active Pharmaceutical Ingredient Value ($) and Growth (%) by Type from 2019-2020
Table Europe Active Pharmaceutical Ingredient Value ($) and Growth (%) by Application from 2019-2020
Table Europe Active Pharmaceutical Ingredient Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Active Pharmaceutical Ingredient Participants Value ($) and Market Share (%) in 2019
Figure Asia-Pacific Active Pharmaceutical Ingredient Production and Growth Rate from 2014-2020
Figure Asia-Pacific Active Pharmaceutical Ingredient Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Active Pharmaceutical Ingredient Import and Export from 2014-2020
Table Asia-Pacific Active Pharmaceutical Ingredient Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Active Pharmaceutical Ingredient Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Active Pharmaceutical Ingredient Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Active Pharmaceutical Ingredient Participants Value ($) and Market Share (%) in 2019
Figure Latin America Active Pharmaceutical Ingredient Production and Growth Rate from 2014-2020
Figure Latin America Active Pharmaceutical Ingredient Consumption and Growth Rate from 2014-2020
Table Latin America Active Pharmaceutical Ingredient Import and Export from 2014-2020
Table Latin America Active Pharmaceutical Ingredient Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Active Pharmaceutical Ingredient Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Active Pharmaceutical Ingredient Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Active Pharmaceutical Ingredient Participants Value ($) and Market Share (%) in 2019
Figure Middle East & Africa Active Pharmaceutical Ingredient Production and Growth Rate from 2014-2020
Figure Middle East & Africa Active Pharmaceutical Ingredient Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Active Pharmaceutical Ingredient Import and Export from 2014-2020
Table Middle East & Africa Active Pharmaceutical Ingredient Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Active Pharmaceutical Ingredient Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Active Pharmaceutical Ingredient Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Active Pharmaceutical Ingredient Participants Value ($) and Market Share (%) in 2019
Table Sun Pharmaceutical Industries Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Sun Pharmaceutical Industries Ltd. Sales and Growth Rate from 2014-2020
Figure Sun Pharmaceutical Industries Ltd. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Merck & Co., Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Merck & Co., Inc. Sales and Growth Rate from 2014-2020
Figure Merck & Co., Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Novartis AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Novartis AG Sales and Growth Rate from 2014-2020
Figure Novartis AG Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Boehringer Ingelheim International GmbH Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Boehringer Ingelheim International GmbH Sales and Growth Rate from 2014-2020
Figure Boehringer Ingelheim International GmbH Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Teva Pharmaceutical Industries Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Teva Pharmaceutical Industries Ltd. Sales and Growth Rate from 2014-2020
Figure Teva Pharmaceutical Industries Ltd. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Bayer AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Bayer AG Sales and Growth Rate from 2014-2020
Figure Bayer AG Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table F. Hoffmann-La Roche Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure F. Hoffmann-La Roche Ltd. Sales and Growth Rate from 2014-2020
Figure F. Hoffmann-La Roche Ltd. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Pfizer Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Pfizer Inc. Sales and Growth Rate from 2014-2020
Figure Pfizer Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Active Pharmaceutical Ingredient Value ($) and Growth Rate Forecast by Regions (2021-2026)
Table Global Active Pharmaceutical Ingredient Production and Growth Rate Forecast by Regions (2021-2026)
Table Global Active Pharmaceutical Ingredient Consumption and Growth Rate Forecast by Regions (2021-2026)
Table Global Active Pharmaceutical Ingredient Production and Growth Rate Forecast by Types (2021-2026)
Table Global Active Pharmaceutical Ingredient Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...